A decade after NLST, the majority of patients in the "developed countries" don't get appropriate screening, testing, or first-line therapy. Who is to blame?
|Ali Musani||University of Colorado|
Why are we failing in screening for lung cancer despite national guidelines and extensive coverage from insurance companies and Medicare?coverage from insurance companies and Medicare?
Is Europe any better in lung cancer screening, proper genetic testing and immune therapies?
|JAVIER FLANDES||Madrid - Fundacion Jimenez Diaz, Spain|